Navigation Links
Increased Heart Attack Risk From Celebrex,Vioxx

CELEBREX (celecoxib capsules) is used for relief of the pain and inflammation of osteoarthritis and adult rheumatoid arthritis. By effectively reducing the pain, inflammation and stiffness of arthritis, celebrex can help you through the day with activities like standing, walking or climbing stairs, and through the night while sitting or lying in bed.

Since their introduction in 1999, the drugs, which are known technically as COX-2 inhibitors, have been among // America's best-selling prescription pharmaceuticals. One of them, Celecoxib, sold as Celebrex, was the sixth leading prescription drug used by 14 million people last year. The other COX-2 inhibitor is Rofecoxib, sold as Vioxx.

The drugs are popular because they provide the same pain- killing effects as aspirin and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) such as ibuprofen, but with less chance of causing ulcers and intestinal bleeding.

Aspirin inhibits two closely related cyclooxygenase enzymes, COX-1 and COX-2. These new drugs specifically inhibit only the COX-2 (which is involved in pain and inflammation) while not affecting the first (which is involved in protecting lining of the stomach).

Celebrex, was recently approved by the Food and Drug Administration, FDA. The popular pain-killers Celebrex and Vioxx may slightly increase a person's risk of having a heart attack, according to an analysis of clinical studies of these 'super aspirin' drugs.


'"/>




Page: 1

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Allergy Risk Increased by Kerosene Use
3. Fewer teeth & Increased Ischemic Stroke risk
4. Young Smokers at Increased Risk Of Developing a Heart Attack
5. Women With Diabetes At Increased Risk Of Developing Cognitive Impairment
6. Asbestos Exposure Associated With An Increased Risk For Autoimmune Disease
7. Schizophrenics On Medication At An Increased Risk For Developing Diabetes
8. Diabetics Found To Be At An Increased Risk Of Developing Cancer
9. Increased Risk For Venous Thrombosis In Cancer Patients
10. Increased risk of common infections in patients suffering from diabetes
11. Infertility Associated With Increased Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... , ... February 05, 2016 , ... US Sports ... Studio in Dover, NH to direct high-performance kids yoga training. ChildLight Yoga Studio is ... just one hour from Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... The American ... technology, such water may be safer than regular municipal or well water. The recent ... radio host Sharon Kleyne, could go a long way toward increasing public acceptance of ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Give To ... users to search for and donate to Give To Cure’s campaign that is crowdfunding ... that lets users make and share payments through a smart device. In 2015 alone, ...
(Date:2/5/2016)... ... February 05, 2016 , ... Pivot Point ... Best in KLAS: Software & Services for HIT Implementation Support & Staffing report ... independently ranks vendor performance by healthcare executives, managers and clinicians representing over 4,500 ...
(Date:2/5/2016)... ... 05, 2016 , ... Dr. Justin Scott and Dr. Lydia Muccioli of ... Day to individuals in need. The event is scheduled to take place on February ... is to provide dental care to community members in need. Each patient will be ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... 2016  Aralez Pharmaceuticals Inc. ("Aralez") today announced the ... Tribute Pharmaceuticals Canada Inc. ("Tribute") following approval of the ... The combined company will operate under Aralez Pharmaceuticals Inc. ... Canada , Ireland ... Under the terms of the Agreement and Plan of ...
(Date:2/5/2016)... New York , February 5, 2016 ... new Transparency Market Research report states that the global ... in 2014 and is predicted to reach US$185.9 bn ... CAGR of 6.50% from 2014 to 2020. The title ... (Branded/Generic/Over-the-counter, Chemical/Biological, Captive/Contract Manufactured, by Geography, and by Therapeutic ...
(Date:2/5/2016)... -- Henry Schein, Inc. (NASDAQ: HSIC ), the world,s largest ... dental, animal health and medical practitioners, announced today that ... majority ownership interest in Dental Cremer S.A., a distributor ... . --> ... dental distribution business of Cremer S.A. With 2015 sales ...
Breaking Medicine Technology: